Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 02, 2021

SELL
$129.91 - $234.98 $28,580 - $51,695
-220 Closed
0 $0
Q1 2021

Apr 12, 2021

SELL
$109.18 - $185.98 $10,153 - $17,296
-93 Reduced 29.71%
220 $29,000
Q4 2020

Jan 22, 2021

SELL
$65.74 - $169.86 $591 - $1,528
-9 Reduced 2.8%
313 $33,000
Q3 2020

Oct 13, 2020

SELL
$54.34 - $94.85 $163 - $284
-3 Reduced 0.92%
322 $23,000
Q2 2020

Jul 09, 2020

BUY
$29.67 - $80.0 $9,642 - $26,000
325 New
325 $21,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Regal Wealth Group, Inc. Portfolio

Follow Regal Wealth Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Wealth Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Regal Wealth Group, Inc. with notifications on news.